Outpatient prescription of pulmonary vasodilator therapy to preterm children with bronchopulmonary dysplasia

Abstract

Bronchopulmonary dysplasia (BPD) is a pulmonary condition and developmental disease that has been associated with premature birth. It has been recognised since the 1960s. 1 Postnatal interventions, such as mechanical ventilation, oxygen, surfactant and systemic corticosteroids, can save lives, but some of these treatments may damage immature lung structures. 2 BPD is currently